All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Pyrazolo[4,3-D]pyrimidines, process for their preparation and methods of use

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15310%2F12%3A33139304" target="_blank" >RIV/61989592:15310/12:33139304 - isvavai.cz</a>

  • Alternative codes found

    RIV/61389030:_____/12:00380690 RIV/61989592:15110/12:33139304

  • Result on the web

  • DOI - Digital Object Identifier

Alternative languages

  • Result language

    angličtina

  • Original language name

    Pyrazolo[4,3-D]pyrimidines, process for their preparation and methods of use

  • Original language description

    The invention relates to 3-, 7-disubstituted pyrazolo[4,3-D]pyrimidines represented by the general formula I (I) and pharmaceutically acceptable salts thereof, wherein R3 is selected from the group consisting of alkyl, cycloalkyl, cycloalkyl alkyl, cycloheteroalkyl alkyl, cycloheteroalkyl aryl, heterocycle, heteroaryl, arylalkyl, heteroarylalkyl, and heteroalkyl, wherein each of the groups may optionally be substituted, R7 is selected from the group consisting of halogen, hydroxyl, hydroxylamino, amino,carboxyl, cyano, nitro, amido, sulfo, sulfamido, carbamino, unsubstituted or substituted alkyl, substituted or unsubstituted cycloalkyl, etc. The invention covers preparation and use of these derivatives.

  • Czech name

  • Czech description

Classification

  • Type

    P - Patent

  • CEP classification

    CC - Organic chemistry

  • OECD FORD branch

Result continuities

  • Project

    <a href="/en/project/GA301%2F08%2F1649" target="_blank" >GA301/08/1649: Modulation of cell division of normal and cancer cells by cyclin-dependent kinase inhibitors</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2012

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Patent/design ID

    CA2524344

  • Publisher

    CA001 -

  • Publisher name

    Canadian Intellectual Property Office (CIPO)

  • Place of publication

    Gatineau, Québec

  • Publication country

    CA - CANADA

  • Date of acceptance

    Mar 13, 2012

  • Owner name

    Univerzita Palackého v Olomouci, CZ a Ústav experimentální botaniky AV ČR, CZ

  • Method of use

    B - Výsledek je využíván orgány státní nebo veřejné správy

  • Usage type

    A - K využití výsledku jiným subjektem je vždy nutné nabytí licence